2025 Speakers Adrianne Wong Director, Oncology Search & Evaluation, Global Business Development Daiichi Sankyo Ajla Hrle Chief Business Officer DISCO Pharmaceuticals Arne Scheu Co-Founder & Chief Executive Officer Valink Therapeutics Barbara Leyman Chief Business Officer Sutro Biopharma Bob Lutz Chief Scientific Officer Iksuda Therapeutics Brian Zhou Associate Director Lily Venture Caitlyn Miller Co-Founder & Chief Executive Officer TwoStep Therapeutics Carla Bauer Director, Oncology Search & Evaluation, Business Development Merck  Chris Hupp Senior Director, Research & External Innovation Ipsen Christoph Korpus Chief Business Officer Byondis Constantine Theodoropulos Co-Founder & Chief Executive Officer GO Therapeutics Cookie Yu Investment Director Samsung Venture Investment Corporation Elena Diez Senior Director, External Innovation Johnson & Johnson Filippo Mulinacci Chief Business Officer Araris Biotech Greco Song Associate Deep Track Capital Hanspeter Gerber Chief Scientific Officer Sutro Biopharma Harris Weber Principal Bain Capital Life Sciences Hong Xin Senior Director, Search & Evaluation Johnson & Johnson Jarrod Longcor Chief Operating Officer Cellectar Biosciences Jason Ruth Sector Lead, Biotech Private Investments Wellington Management Jenny Wang Director II, Search & Evaluation Oncology AbbVie Joe Nabhan Chief Scientific Officer K2B Therapeutics John Mayfield Senior Vice President, Business Development & Strategy Flagship Pioneering Juanjo Cragnolini Associate Director, Search & Evaluation, Oncology Takeda Kinney Horn Chief Business Officer Immunome Marc Robillard Founder & Chief Scientific Officer Tagworks Pharmaceuticals Matthew Metzger Program, Alliance & Business Development Manager Oxford Biotechnologies Natalie Tucker Senior Vice President – Radioligand Therapies Y-mAbs Therapeutics Patrick Beusker Director, Medicinal & Protein Chemistry Byondis Patrick Zweidler- McKay Chief Medical Officer Sidewinder Therapeutics Robin Carr Chief Executive Officer Myricx Bio Steve Bartz Head of Oncology Search & Evaluation Pfizer Steven Everett Chief Executive Officer MaveriX Oncology Tim Wang Chief Business Officer Duality Biologics Travis Biechele Vice President, Research Shasqi Valerie Vanhooren Co-founder & Chief Executive Officer Ona Therapeutics Yangzi He Associate Director, Business Development - Oncology & Hematology, Search & Evaluation BMS View Agenda Buy Ticket To the top
